Published online Jun 28, 2021. doi: 10.35711/aimi.v2.i3.56
Peer-review started: April 10, 2021
First decision: April 28, 2021
Revised: May 6, 2021
Accepted: June 4, 2021
Article in press: June 4, 2021
Published online: June 28, 2021
Processing time: 89 Days and 11.1 Hours
Lung ultrasound (US) has been shown that it is able to detect interstitial lung disease, subpleural consolidations and acute respiratory distress syndrome in clinical and physical studies that assess its role in upper respiratory infections. It is used worldwide in the coronavirus disease 2019 (COVID-19) outbreak and the effectiveness has been assessed in several studies. Fast diagnosis of COVID-19 is essential in deciding for patient isolation, clinical care and reducing transmission. Imaging the lung and pleura by ultrasound is efficient, cost-effective, and safe and it is recognized as rapid, repeatable, and reliable. Obstetricians are already using the US and are quite proficient in doing so. During the pandemic, performing lung US (LUS) right after the fetal assessment until reverse transcription polymerase chain reaction results are obtained, particularly in settings that have a centralized testing center, was found feasible for the prediction of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The use of LUS is efficient in the triage and monitoring of pregnant women. Clinicians dealing with pregnant women should consider LUS as the first-line diagnostic tool in pregnant women during the SARS-CoV-2 pandemic.
Core Tip: Lung ultrasound (US) is based on specific pattern recognition and does not require complex measurements, therefore obstetricians can easily learn and use lung ultrasound (LUS) in the pandemic. LUS examination can be a routine after a routine obstetric US examination. Fast diagnosis of coronavirus disease 2019 is essential in deciding for patient isolation, clinical care, and reducing transmission. Clinicians dealing with pregnant women should consider LUS as the first-line diagnostic tool in pregnant women during the severe acute respiratory syndrome coronavirus 2 pandemic.